Retatrutide, often called RETA, is an investigational molecule targeting GIP, GLP-1 and glucagon receptors. Lilly describes it as unapproved. A RETA-labelled bottle is not evidence that it is the product studied in a clinical trial.
Illustration retained from the original article; not a verified product photograph.
Primecorebio RETA here refers to the AI illustration of a yellow-labelled vial bearing primecorebio, RETA 10 MG, Retatrutide and 1 vial wording, alongside FOR RESEARCH USE ONLY and NOT FOR HUMAN USE. Text in the image does not verify a manufacturer, contents or quantity in a physical vial.
Why is it called a triple agonist?
The term describes three receptor targets. It is neither a brand nor a recipe for combining substances, and receptor count alone does not establish superiority.
How does it differ from tirzepatide and semaglutide?
Tirzepatide targets GIP and GLP-1; semaglutide is a GLP-1 receptor agonist. Read mechanism alongside product status and study design, rather than comparing results from unrelated trials as if they were head-to-head.
Research and brand images are different evidence
Primecorebio imagery and Wellness/SA names identify what the site is discussing. They do not verify the manufacturer, contents or test results of a particular bottle. Product verification needs its readable label and corresponding documentation.
Frequently asked questions
Is RETA an approved medicine name?
RETA is a shorthand for retatrutide. The Lilly source reviewed here still describes retatrutide as unapproved.
Does the Primecorebio image represent Lilly trial evidence?
No. An illustration and Lilly clinical-trial evidence are different sources; the image does not verify product quality or outcomes.
Where can I read about listing names?
Use the retatrutide category and Wellness entry below to distinguish pictured names from the substance’s research status.
Read next
What is tirzepatide? Medicine names, mechanism and listing differences · What is semaglutide? Wegovy, Ozempic and brand-specific evidence · Retatrutide · SA Tirzep and SA Reta: image names, tirzepatide and retatrutide
Sources
- Lilly — Retatrutide research status
- Lilly — Mounjaro prescribing information
- Novo Nordisk — Ozempic prescribing information
Research and medicine labels above are separate from evidence for this listing image.
For general name or label questions, contact LINE: @musclestationth